Seminar Videos
Fall 2022 – Spring 2023
Fall 2021 – Spring 2022
Fall 2020 – Spring 2021
- June 4 – Richard “RJ” Marrero, Graduate Research Assistant & McKnight Doctoral Fellow, Department of Pharmacotherapy and Translational Research: “Clinical Outcomes Genome-wide Association Study in Pediatric Acute Myeloid Leukemia”
- May 28 – Andrew Tenpas, PharmD, PGY2 Ambulatory Care Resident, Department of Pharmacotherapy and Translational Research: “Measuring Impact and Increase in Access from Pharmacist-Led Chronic Care Management (CCM) Services In A Rural Family Medicine Clinic”
- May 24 – Benish Alan, PharmD, PGY2 Clinical Pharmacogenomics Resident, Department of Pharmacotherapy and Translational Research: “Grassroots impact: evaluating the role of a pharmacogenetic specialist in a dynamic health system”
- May 21 – Angelina Vascimini, PharmD, PGY2 Ambulatory Care Resident, Department of Pharmacotherapy and Translational Research: “Fostering community and ambulatory care pharmacist communication to improve medication safety in a rural setting”
- May 17 – Colleen Courey, PharmD, PGY1 Community-Based Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Surveying the Influence of COVID-19 on Flu Vaccinations”
- May 14 – Kimberly Atkinson, PharmD, PGY1 Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Pharmacists Increasing Access to Diabetes Supplies to Patients with Type 2 Diabetes Mellitus in a Primary Care Setting”
- May 10 – Joey Dabringer, PharmD, PGY1 Community-Based Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Adaptations in Community Pharmacy During COVID-19 to Increase Access to Care”
- May 7 – Amanda Elchynski, PharmD, Clinical Pharmacogenomics Fellow, Department of Pharmacotherapy and Translational Research: “Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support for CYP2D6 and CYP2C19”
- May 3 – Yimei Huang, PharmD, Graduate Student and Teaching Assistant, Department of Pharmacotherapy and Translational Research: “Genome-wide Association Study to Identify Genetic Determinants of Heart Failure Morbidity and Mortality”
- April 16 – Nathan Seligson, PharmD, Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research: “Genomic Heterogeneity in Fusion Driven Sarcoma”
- April 9 – Chardaé Whitner, PharmD, Community Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Overcoming COVID-19 Vaccination Barriers in Low-Income Communities”
- March 26 – Casey Rowe, PharmD, Medication Therapy Management Resident, Department of Pharmacotherapy and Translational Research: “Improving the Prior Authorization Process”
- March 12 – George L. Drusano, MD, Professor & Director, UF Institute for Therapeutic Innovation: “The Big Picture for P01AI123036: Developing New Drugs and Regimens for Mycobacterium tuberculosis”
- February 26 – Jasmine Luzum, PharmD. Ph.D, University of Michigan College of Pharmacy: “Race-Based Drug Recommendations in Cardiology”
- February 19 – Aiming Yu, Ph.D., Department of Biochemistry and Molecular Medicine, UC Davis Health School of Medicine: “The next generation of therapeutics: RNA-based medications”
- February 5 – Christelle Lteif, Graduate Student, Department of Pharmacotherapy and Translational Research: “Potential Therapeutic Targets for Pulmonary Hypertension in Left Heart Failure”
- January 15 – Cameron Thomas, PharmD, Graduate Student, Department of Pharmacotherapy and Translational Research: “Feasibility and Efficacy of CYP2D6 Genotyping in Patients Undergoing Total Joint Arthroplasty”
- December 4 – Joe Collins, PhD, Postdoctoral Researcher, Department of Pharmacotherapy and Translational Research: “Regulation that Ignores Social Distancing: Enhancers in the CYP3A Cluster”
- November 20 – Martina Hahn, PharmD, Clinic for Psychiatry, Psychosomatics, and Psychotherapy, University Hospital Frankfurt: “Pharmacy system in Germany – current challenges in Corona times”
- November 13 – Yuli Qian, M.S., Graduate Student, Department of Pharmacotherapy and Translational Research: “Prediction of pharmacokinetic interactions between methylphenidate and cannabinoids”
- November 6 – Leanne Dumeny, Graduate Student, Department of Pharmacotherapy and Translational Research & Genetics Institute: “Heart Failure Therapies and Pharmacogenomic Applications”
- October 30 – Carolin Werkman, Graduate Student, Department of Pharmacotherapy and Translational Research: “Identification of Penicillin Binding Protein receptor occupancy profiles that maximize bacterial killing in Acinetobacter baumannii 3681”
- October 23 – Mai Mehanna, Graduate Assistant, Department of Pharmacotherapy and Translational Research: “Plasma Renin Activity in Optimizing Precision of Hypertension Care in European and African Americans”
- October 16 – Mohammad Gbadamosi, Graduate Student, Department of Pharmacotherapy and Translational Research: “Novel CD33 Antibodies Reveal New Strategies for Advances in CD33 Immunotherapy”
- October 9 – Vivek Shastri, Postdoctoral Associate, Department of Pharmacotherapy and Translational Research: “A five SNP score predicts to gemtuzumab ozogamicin in acute myeloid leukemia patients: A calicheamicin-direct pathway analysis from the COG-AAML0531 trial”
- September 25 – Eunjeong (Elena) Shin, Graduate Student, Department of Pharmacotherapy and Translational Research: “Optimizing Therapies to Elicit Extensive Bacterial Killing without Resistance against Klebsiella Pneumoniae”
- September 18 – Leslie Hendeles, PharmD, Professor Emeritus, Department of Pharmacotherapy and Translational Research: “Update on Drug Therapy of Asthma”
- September 11 – Abdelrahman H. Elsayed, MSc, Graduate Research Assistant, Department of Pharmacotherapy and Translational Research: “Comprehensive Ara-C PGx Based Prognostic Score Hold Promise in Strategizing Treatment Options for Pediatric AML Patients”
- August 28 – Christopher R. Piszczatoski, PharmD, Postdoctoral Fellow in Family Medicine, Department of Pharmacotherapy and Translational Research: “Incorporation of DOAC Management to Pharmacy-Led Anticoagulation Services in the Primary Care Setting”